Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Dr. Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Chinese Academy of Medical Sciences and Peking Union Medical College | ChinaĀ 

Author Profile

ScopusĀ 

Orcid ID

šŸ“˜ KUANGYU YEN, PhD: PIONEER IN TRANSCRIPTION REGULATION AND CHROMATIN DYNAMICS

šŸŽ“ EARLY ACADEMIC PURSUITS

Kuangyu Yen's academic journey began at National Taiwan University, where he earned a Bachelor of Science in Horticulture (Molecular Biology Unit) in 1998. His passion for molecular biology led him to pursue advanced degrees at the University of Manchester, UK, where he completed both an MRes (2001) and a Ph.D. in Molecular Biology (2005). His doctoral research laid the foundation for his expertise in transcription regulation, setting the stage for his future research endeavors.

šŸ’¼ PROFESSIONAL ENDEAVORS

Dr. Yen's professional career is marked by a blend of international experiences and prestigious appointments:

  • Chinese Academy of Medical Sciences & Peking Union Medical College (2022-present): Researcher.
  • Southern Medical University (2014-2022): Professor, where he contributed significantly to the academic and research community in Guangzhou, China.
  • Pennsylvania State University (2008-2014): Post-doctoral fellow and later Research Assistant Professor, expanding his expertise in transcription regulation and chromatin dynamics.
  • University of Washington (2005-2007): Post-doctoral fellow, further deepening his understanding of molecular biology at the intersection of chromatin and transcription.
  • National Taiwan University (1998-2000): Research Assistant, where his scientific curiosity began to flourish.

šŸ”¬ CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATION AND EPIGENETICS

Dr. Yen's research focus is on transcription regulation and its influence on cell fate determination, particularly through chromatin dynamics. His innovative use of bioinformatic tools, CRISPR/Cas9-engineered depletion, and biochemical reconstitution has made him a leader in understanding how chromatin regulates transcription in a spatiotemporal manner. His research has significant implications for disease diagnosis and treatment, especially in preventing precancerous cells from progressing into cancer cells.Ā One of his notable contributions is the development of a two-tipping point model, which helps explain how cell fate transitions. This model has potential applications in both basic research and clinical practice, offering insights into the molecular mechanisms of various diseases.

šŸŒ IMPACT AND INFLUENCE

Dr. Yenā€™s work has been internationally recognized, and he has secured multiple high-profile grants and awards, such as the Thousand Youth Talents Award and the Outstanding Youth Award. His research has attracted funding from the National Natural Science Foundation of China, the National Key Research and Development Program of China, and international collaborations such as the France-China Joint Research Projects Program. His influence extends to key speaking engagements and workshops in the field of epigenetics and hematopoiesis at global institutions, including John Hopkins University.

šŸ“Š ACADEMIC CITATIONS

With several publications to his name, Dr. Yenā€™s work is well-cited in the scientific community, reinforcing his status as an influential researcher in molecular biology. His contributions to understanding transcription regulation and chromatin dynamics continue to resonate, particularly in the areas of epigenetics and hematopoiesis.

šŸŒŸ LEGACY AND FUTURE CONTRIBUTIONS

Kuangyu Yenā€™s legacy will likely center on his pioneering research into how chromatin structure affects transcriptional regulation and cell fate transitions. His use of cutting-edge tools like CRISPR/Cas9 and bioinformatics has laid the groundwork for future advancements in cancer prevention and molecular diagnostics.Ā Moving forward, Dr. Yenā€™s ongoing research at the Chinese Academy of Medical Sciences is poised to further influence how scientists understand and manipulate transcription regulation. His editorial role at Communication Biology (2024-2026) and other professional activities suggest that his contributions to the field are far from over.

šŸš€ AWARDS AND PROFESSIONAL RECOGNITION

  • National Natural Science Foundation of China: Multiple grants for outstanding research, totaling over 500,000 USD.
  • Thousand Youth Talents Award: A prestigious recognition with funding of 0.67 million USD.
  • Numerous invited talks at top-tier institutions and international conferences.

Kuangyu Yenā€™s continuous dedication to his research and the academic community positions him as a transformative figure in molecular biology, with future contributions set to further shape the field.

šŸ“… FUTURE HIGHLIGHTS

Dr. Yenā€™s ongoing projects and his active engagement with the scientific community, including participation in international editorial boards and professional panels, indicate that his work will continue to shape the future of molecular biology research for years to come.

šŸ“‘NOTABLE PUBLICATIONSĀ 

"RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation"Ā 

  • Authors: Liu, S., Yang, J., Sun, G., Yen, K., & Lu, T. (2021).
  • Journal: Molecular Biosciences
  • Year: 2021

"Chemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae"Ā 

  • Authors: Lai, S., Kumari, A., Liu, J., Yen, K., & Xu, J.
  • Journal: Genetics and Genomics
  • Year: 2021

"Comprehensive understanding of Tn5 insertion preference improves transcription regulatory element identification"

  • Authors: Zhang, H., Lu, T., Liu, S., Chen, F., & Yen, K.
  • Journal: NAR Genomics and Bioinformatics
  • Year: 2021

"Functional Verification of Novel ELMO1 Variants by Live Imaging in Zebrafish"

  • Authors: Xue, R., Wang, Y., Wang, T., Liu, Q., & Xu, J.
  • Journal: Frontiers in Cell and Developmental Biology
  • Year: 2021

"SPI1-KLF1/LYL1 axis regulates lineage commitment during endothelial-to-hematopoietic transition from human pluripotent stem cells"

  • Authors: Qu, K., Mo, S., Huang, J., Shen, J., & Yen, K.
  • Journal: iScience
  • Year: 2024

Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Prof Dr. Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Nanjing Medical University | China

AUTHOR PROFILE

Scopus

orcid ID

EARLY ACADEMIC PURSUITS

Wei Wu began his academic journey at Nanjing Medical University, where he earned a Bachelor of Science in Preventive Medicine in 2007. He continued his studies at the same institution, obtaining a Ph.D. in Toxicology in 2012. His doctoral research was conducted in the Department of Toxicology, focusing on toxicological mechanisms and their implications for public health. Following his Ph.D., Wu completed a postdoctoral fellowship in Reproductive and Developmental Toxicology at the State Key Laboratory of Reproductive Medicine, also at Nanjing Medical University. In 2017-2018, he broadened his research horizons as a guest researcher at the National Institute of Environmental Health Sciences in the United States, specializing in Epidemiology.

PROFESSIONAL ENDEAVORS

Wei Wu's professional career is anchored at Nanjing Medical University, where he has ascended from a research assistant to a professor. His roles include:

  • 2022-present: Professor, Department of Toxicology, School of Public Health
  • 2022-present: Assistant Dean, School of Public Health
  • 2022-present: Secretary General, Jiangsu Society of Toxicology
  • 2021-present: Associate Department Chair, Department of Scientific Research Sharing Platform (Core Facility)
  • 2018-present: Associate Department Chair, Department of Toxicology
  • 2016-2022: Associate Professor, Department of Toxicology
  • 2012-2016: Lecturer, Department of Toxicology
  • 2010-2012: Research Assistant, School of Public Health

CONTRIBUTIONS AND RESEARCH FOCUS ON DNA METHYLATION AND MALE REPRODUCTIVE HEALTH

Wei Wu has made significant contributions to the field of toxicology, particularly in reproductive and developmental toxicology. His research has focused on the toxicological effects of environmental and chemical exposures on reproductive health. His work also delves into the molecular mechanisms underlying these toxicological impacts, aiming to develop preventive strategies and therapeutic interventions.

IMPACT AND INFLUENCE

Wei Wu has received numerous honors and awards that reflect his impact and influence in the field of toxicology. Notable accolades include:

  • 2023: "Good Youth Around Us" by the Communist Youth League Jiangsu Provincial Committee
  • 2022: Friendship Teaching Award of Nanjing Medical University
  • 2020: Ministry of Education Fok Ying Tung Young Teachers' Award
  • 2019: Clarivate Publons Peer Review Awards (top 1% reviewers in Crossfield and Clinical Medicine)
  • 2018: Publons Peer Review Awards (top 1% reviewers in Clinical Medicine)
  • 2017: Multiple awards for excellent papers and teaching achievements

ACADEMIC CITATIONS

Wei Wu holds various editorial positions, contributing to the dissemination of scientific knowledge in toxicology and related fields. He serves on the editorial boards of several prestigious journals, including:

  • Scientific Reports
  • SM Journal of Environmental Toxicology
  • Global Journal of Genitourinary Cancer
  • Austin Journal of Reproductive Medicine & Infertility
  • Journal of Clinical Obstetrics, Gynecology & Infertility
  • Medicine
  • Frontiers in Endocrinology
  • Frontiers in Physiology

As an editor-in-chief, he leads the International Journal of Sexual Health and Reproductive Health Care and the Research International Journal of Endocrinology and Diabetes.

LEGACY AND FUTURE CONTRIBUTIONS

Wei Wuā€™s ongoing research and professional activities suggest a lasting legacy in the field of toxicology. His leadership roles within professional societies, such as the Jiangsu Society of Toxicology and the Jiangsu Provincial Preventive Medical Association, underline his influence in shaping future research directions and policies. His dedication to teaching and mentoring the next generation of toxicologists ensures that his impact will continue to resonate in the academic and scientific communities.

NOTABLE PUBLICATIONS

Hongmeng Su | Gene Regulations |Ā Best Researcer Award

Dr. Hongmeng Su | Gene Regulations and Epigenetics |Ā  Best Researcer Award

Southeast University | China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Hongmeng Su embarked on an academic journey marked by a strong foundation in bioengineering, which laid the groundwork for subsequent achievements. Graduating with a Bachelor of Engineering in Bioengineering from Nanjing Agriculture University in 2019, Su's early academic pursuits showcased a dedication to biological sciences and a burgeoning interest in research.

PROFESSIONAL ENDEAVORS

Transitioning seamlessly from undergraduate to graduate studies, Su pursued a Master of Science in Biology at the School of Life Science and Technology, Southeast University, from 2019 to 2021. This period not only honed Su's research skills but also provided a platform for academic growth and exploration in the field of biology.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATIONS AND EPIGENETICS

Su's contributions to the field of medical genetics and developmental biology are underscored by a multifaceted approach to understanding the molecular mechanisms driving hepatocellular carcinogenesis. Through meticulous research endeavors, Su has delved into the intricate interplay between non-coding RNA, transcription factors, and carcinogenesis, shedding light on key pathways implicated in cancer progression and metastasis.

IMPACT AND INFLUENCE

Su's research findings have garnered recognition and accolades, affirming the significance of their contributions to the scientific community. Notably, Su's report on the combined analysis of m6A and m5C RNA methylation modulators received honorable mention at the 10th Member Congress and Academic Seminar of Jiangsu Genetic Association, showcasing the impact of their work on hepatocellular carcinoma prognosis.

ACADEMIC CITATIONS

Su's scholarly endeavors have contributed to the advancement of knowledge in medical genetics, developmental biology, and cancer research. Their publications serve as a testament to their dedication to scientific inquiry and the dissemination of impactful findings within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As a Ph.D. candidate at the Department of Medical Genetics & Developmental Biology, School of Medicine, Southeast University, Su's legacy is characterized by a commitment to unraveling the complexities of hepatocellular carcinogenesis. Armed with a diverse skill set encompassing molecular and cellular experimentation, bioinformatics analysis, and statistical modeling, Su is poised to make enduring contributions to the field of cancer biology and beyond. Their future endeavors hold the promise of further elucidating the molecular underpinnings of cancer progression, informing novel therapeutic strategies, and ultimately, advancing human health.

Notable Publications

TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p 2021(35)

ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression

Prognostic value of PD-L1 expression combined with hypoxia-associated immunosuppression in hepatocellular carcinoma